Dexmedetomidine in awake implantation of neuromodulative systems.
Phase of Trial: Phase II
Latest Information Update: 06 Jul 2015
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Acronyms DexMed
- 04 Jul 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 19 Aug 2014 New trial record